Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS

NCT04615429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome
COVID-19 Pneumonia

Interventions

BIOLOGICAL: Mesenchymal stromal cells
OTHER: Placebo

Sponsor

Cristina Avendaño Solá